Hassan Albadawi

Hassan Albadawi

Auto-generated profile, based on publicly available information

Hassan Albadawi

Laboratory for Patient-Inspired Engineering, Mayo Clinic, 13400 East Shea Blvd., Scottsdale, AZ 85259, USA

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 February 2021 in Science Translational Medicine
Verified
Journal Article
Closed access
PDF file
HAHassan Albadawi
Hassan Albadawi
ZZZefu Zhang
Zefu Zhang
IAIzzet Altun
Izzet Altun
Jingjie HuJingjie Hu
Jingjie Hu
LJLeila Jamal
Leila Jamal
RORahmi Oklu
Rahmi Oklu
An ionic liquid formulation ablates tumors, uniformly distributes drugs in the ablation zone, and has synergistic effects with chemotherapy.

1 August 2016 in Journal of Vascular Surgery
Verified
Journal Article
Closed access
HAHassan Albadawi
Hassan Albadawi
RORahmi Oklu
Rahmi Oklu
RMRita Elise Raacke Malley
Rita Elise Raacke Malley
RORyan M. O'KEefe
Ryan M. O'KEefe
TUThuy P. Uong
Thuy P. Uong
MWMichael T. Watkins
Michael T. Watkins

1 November 2017 in Oncolytic Virotherapy
Verified
Journal Article
Open access
PDF file
RYRaquel Yokoda
Raquel Yokoda
BNBolni M Nagalo
Bolni M Nagalo
BVBrent Vernon
Brent Vernon
RORahmi Oklu
Rahmi Oklu
HAHassan Albadawi
Hassan Albadawi
MBMitesh J. Borad
Mitesh J. Borad
With the advancement of a growing number of oncolytic viruses (OVs) to clinical development, drug delivery is becoming an important barrier to overcome for optimal therapeutic benefits. Host immunity, tumor microenvironment and abnormal vascularity contribute to inefficient vector delivery. A number of novel approaches for enhanced OV delivery are under evaluation, including use of nanoparticles, immunomodulatory agents and complex viral–particle ligands along with manipulations of the tumor microenvironment. This field of OV delivery has quickly evolved to bioengineering of complex nanoparticles that could be deposited within the tumor using minimal invasive image-guided delivery. Some of the strategies include ultrasound (US)-mediated cavitation-enhanced extravasation, magnetic viral complexes delivery, image-guided infusions with focused US and targeting photodynamic virotherapy. In addition, strategies that modulate tumor microenvironment to decrease extracellular matrix deposition and increase viral propagation are being used to improve tumor penetration by OVs. Some involve modification of the viral genome to enhance their tumoral penetration potential. Here, we highlight the barriers to oncolytic viral delivery, and discuss the challenges to improving it and the perspectives of establishing new modes of active delivery to achieve enhanced oncolytic effects.

12 August 2019 in Abdominal Radiology
Verified
Journal Article
Closed access
SASadeer J. Alzubaidi
Sadeer J. Alzubaidi
IPIndravadan J Patel
Indravadan J Patel
ASAman Saini
Aman Saini
GKGrace Knuttinen
Grace Knuttinen
SNSailendra Naidu
Sailendra Naidu
RORahmi Oklu
Rahmi Oklu

1 August 2013 in Surgery
Verified
Journal Article
Closed access
MSMartin Sillesen
Martin Sillesen
GJGuang Jin
Guang Jin
RORahmi Oklu
Rahmi Oklu
HAHassan Albadawi
Hassan Albadawi
AIAyesha M. Imam
Ayesha M. Imam
HAHasan B. Alam
Hasan B. Alam

1 January 2017 in Radiology
Verified
Journal Article
Closed access
HAHassan Albadawi
Hassan Albadawi
JCJohn W. Chen
John W. Chen
RORahmi Oklu
Rahmi Oklu
YWYue Wu
Yue Wu
GWGregory Wojtkiewicz
Gregory Wojtkiewicz
MWMichael T. Watkins
Michael T. Watkins
The proinflammatory enzyme myeloperoxidase, which is secreted by activated myeloid cells, could represent a key imaging biomarker for tracking early inflammatory changes noninvasively in the spinal... PurposeTo evaluate whether noninvasive molecular imaging technologies targeting myeloperoxidase (MPO) can reveal early inflammation associated with spinal cord injury after thoracic aortic ischemia...